Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

Author： Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.78, Iss.5, 2002-11, pp. : 1049-1054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1086-1093

Elsevier

Access to resources Recommend Favorite

Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin

By Meo F.   Ranieri D.M.   Khadum I.   Serhal P.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 630-632

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1121-1122

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study

By Westergaard L.G.   Erb K.   Laursen S.B.   Rex S.   Rasmussen P.E.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 543-549

Elsevier

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

By Kelly E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1105-1107

Elsevier

Access to resources Recommend Favorite